Exane Derivatives’s Reynolds American Inc RAI Stock Holding History

Exane Derivatives’s Portfolio RAI Stock Details RAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,000	Closed	-$665K	–	708
2016 Q4	$665K	Hold	1,000	–	–	0.13%	134
2016 Q3	$70K	Buy	+1,000	New	+$50.2K	0.01%	272
2016 Q2	–	Sell	-1,000	Closed	-$365K	–	645
2016 Q1	$365K	Sell	1,000 -2,740	-73%	-$135K	0.05%	157
2015 Q4	$3.02M	Sell	3,740 -100	-3%	-$4.63K	0.41%	51
2015 Q3	$2.38M	Buy	3,840 +1,000	+35%	+$41.5K	0.3%	59
2015 Q2	$1.06M	Hold	2,840	–	–	0.11%	87
2015 Q1	$647K	Sell	2,840 -1,760	-38%	-$61.7K	0.07%	121
2014 Q4	$1.9M	Buy	+4,600	New	+$146K	0.26%	68

Other funds holding RAI

WIM

Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

MDCM

Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return

Exane Derivatives's RAI Position: Q3 2017 in Review

Exane Derivatives sold out of Reynolds American Inc (RAI) in Q3 2017, closing a stake of 92,603 shares — an estimated $6.02M sold.

Exane Derivatives first reported a position in RAI in Q4 2014 and held it in 8 quarters. The position peaked at $20.5M in Q2 2015. 3 funds tracked by Wall St. Rank hold RAI as of Q3 2017.

Exane Derivatives reported no remaining Reynolds American Inc position as of Q3 2017 after selling out during the quarter.
Exane Derivatives sold 92,603 Reynolds American Inc shares in Q3 2017, an estimated $6.02M.
Exane Derivatives first reported a position in Reynolds American Inc in Q4 2014 and held it in 8 quarters.
Exane Derivatives's Reynolds American Inc position peaked at $20.5M in Q2 2015.
3 funds tracked by Wall St. Rank held Reynolds American Inc as of Q3 2017.

Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.